Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED v. TEVA PHARMACEUTICALS, INC. et al
Case Number:
2:23-cv-00018
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
- Carella Byrne
- Carlton Fields
- Cozen O'Connor
- Fox Rothschild
- Goodwin Procter
- Hill Wallack
- Lerner David
- Midlige Richter
- Pergament & Cepeda
- Quinn Emanuel
- Rivkin Radler
- Saul Ewing
- Stone Conroy LLC
- Taft Stettinius
- Walsh Pizzi
Companies
- Alkem Laboratories Ltd.
- Altaris Capital Partners LLC
- Apotex Inc.
- Cipla Ltd.
- Jazz Pharmaceuticals Inc.
- Lupin Ltd.
- Taro Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
-
January 11, 2024
NJ Judge Not Convinced Epidiolex Seller Lied To USPTO
A New Jersey federal judge on Thursday dismissed allegations that 19 Jazz Pharmaceuticals patents covering its epilepsy treatment Epidiolex aren't enforceable, saying there's no evidence that the company lied to the patent office to dodge higher fees.
-
July 18, 2023
CBD Co. Wants Counterclaims Nixed In Epidiolex Patent Row
British pharmaceutical firm GW Pharmaceuticals has urged a New Jersey federal judge to toss counterclaims lodged by InvaGen Pharmaceuticals in a patent dispute regarding GW's flagship CBD-derived epilepsy treatment Epidiolex.
-
January 05, 2023
CBD Drug Co. Alleges Teva, Others Violated Patents
British pharmaceutical firm GW Pharmaceuticals has accused a dozen drug manufacturers, including Teva Pharmaceuticals, of violating its patents when they sought approval to sell generic versions of the company's flagship CBD-derived epilepsy treatment Epidiolex.